Home › Follicular Lymphoma › Minnesota › Rochester

Pag-aaral pangklinika para sa Follicular Lymphoma sa Rochester, MN

Isang pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Nagre-recruitPhase 1/2

Research Site, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06542250

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Mayo Clinic - Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

Mayo Clinic - Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

Mayo Clinic - Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Mayo Clinic, Clinical Trials Referral Office, Rochester

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Nagre-recruitPhase 1/2

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT07468136

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT04669171

Q702 for the Treatment of Patients With Hematologic Malignancies

Nagre-recruitPhase 1

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 10, 2025 · NCT06712810

Pag-aaral para sa Follicular Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Rochester

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.